Back to Browse Journals » Medicolegal and Bioethics » Volume 2

REACH, animal testing, and the precautionary principle

Authors Menache A, Nastrucci C

Received 19 April 2012

Accepted for publication 11 May 2012

Published 6 August 2012 Volume 2012:2 Pages 13—29


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Video abstract presented by Andre Menache

Views: 500

Andre Menache,1 Candida Nastrucci2

1Antidote Europe, Perpignan, France; 2University of Rome, "Tor Vergata", Rome, Italy

Abstract: Relatively little is known about the toxicity of the many chemicals in existence today. This has prompted European Union regulatory authorities to launch a major chemicals testing program, known as Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). Although the driving force behind REACH is ostensibly based on the precautionary principle, in practice, the evidence suggests that it is oriented more toward risk assessment than precaution. In addition, the test methods used to assess chemical risk also raise questions about the efficacy of REACH in achieving its stated aims of protecting human health and the environment. These tests rely in large part on animal models. However, based on empirical evidence and on well-established principles of evolutionary biology and complex systems, the animal model fails as a predictive modality for humans. In turn, these concerns raise significant ethical and legal issues that must be addressed urgently. Immediate measures should include a major biomonitoring program to reliably assess the chemical burden in European Union citizens as a means of prioritizing the most dangerous substances present in the environment. Blood and urine biomarkers are useful tools with which to implement biomonitoring and to help guide public policy. An ecological paradigm, based on pollution prevention, rather than pollution control and risk assessment of individual chemicals, represents a superior strategy, to prevent global chemical pollution and toxicity risks to human health.

Keywords: precautionary principle, risk, chemicals, animal tests, biomonitoring

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Readers of this article also read:

Effects of different resistance training frequencies on flexibility in older women

Carneiro NH, Ribeiro AS, Nascimento MA, Gobbo LA, Schoenfeld BJ, Achour Júnior A, Gobbi S, Oliveira AR, Cyrino ES

Clinical Interventions in Aging 2015, 10:531-538

Published Date: 5 March 2015

Oral lipid-based nanoformulation of tafenoquine enhanced bioavailability and blood stage antimalarial efficacy and led to a reduction in human red blood cell loss in mice

Melariri P, Kalombo L, Nkuna P, Dube A, Hayeshi R, Ogutu B, Gibhard L, deKock C, Smith P, Wiesner L, Swai H

International Journal of Nanomedicine 2015, 10:1493-1503

Published Date: 20 February 2015

The relationship between Graves’ ophthalmopathy and dry eye syndrome

Selter JH, Gire AI, Sikder S

Clinical Ophthalmology 2015, 9:57-62

Published Date: 31 December 2014

Electrospun fibrous scaffolds combined with nanoscale hydroxyapatite induce osteogenic differentiation of human periodontal ligament cells

Wu XN, Miao LY, Yao YF, Wu WL, Liu Y, Chen XF, Sun WB

International Journal of Nanomedicine 2014, 9:4135-4143

Published Date: 27 August 2014

Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION–EGF) for targeting brain tumors

Shevtsov MA, Nikolaev BP, Yakovleva LY, Marchenko YY, Dobrodumov AV, Mikhrina AL, Martynova MG, Bystrova OA, Yakovenko IV, Ischenko AM

International Journal of Nanomedicine 2014, 9:273-287

Published Date: 3 January 2014

30-day hospital readmission of older adults using care transitions after hospitalization: a pilot prospective cohort study

Takahashi PY, Haas LR, Quigg SM, Croghan IT, Naessens JM, Shah ND, Hanson GJ

Clinical Interventions in Aging 2013, 8:729-736

Published Date: 18 June 2013

Insulin resistance and inflammation markers in myocardial infarction

Gruzdeva O, Uchasova E, Dyleva Y, Belik E, Shurygina E, Barbarash O

Journal of Inflammation Research 2013, 6:83-90

Published Date: 17 June 2013

Improved oral bioavailability of poorly water-soluble indirubin by a supersaturatable self-microemulsifying drug delivery system

Chen ZQ, Liu Y, Zhao JH, Wang L, Feng NP

International Journal of Nanomedicine 2012, 7:1115-1125

Published Date: 23 February 2012